Venus Remedies Limited (BOM:526953)

Market Cap	10.06B
Revenue (ttm)	6.99B
Net Income (ttm)	703.05M
Shares Out	13.37M
EPS (ttm)	52.64
PE Ratio	14.30
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,242
Average Volume	19,763
Open	808.50
Previous Close	770.45
Day's Range	731.95 - 808.50
52-Week Range	272.20 - 808.50
Beta	0.32
RSI	73.53
Earnings Date	Nov 10, 2025

About Venus Remedies

Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology. The company also offers analgesic, analgesic and antipyretic, antibiotic, anticoagulant, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones (steroid), immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, and solvent products, as well as herbal medicine. The c...

• Industry: Pharmaceutical Preparations
• Founded: 1989
• Employees: 1,298
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 526953

Financial Performance

In 2024, Venus Remedies's revenue was 6.48 billion, an increase of 7.72% compared to the previous year's 6.01 billion. Earnings were 453.15 million, an increase of 59.05%.